Peptic Ulcer Disease (PUD) remains a prevalent gastrointestinal disorder with significant morbidity and mortality. As healthcare professionals, it is vital to adopt a comprehensive approach to its management to achieve optimal patient outcomes.
Understanding the pathophysiology of PUD is key to effective management. It involves an imbalance between the aggressive factors (H. pylori, NSAIDs, acid, pepsin) and defensive mechanisms (mucus, bicarbonate, blood flow, prostaglandins) of the gastric mucosa.
Accurate diagnosis and risk stratification are essential. This includes history taking, physical examination, laboratory tests, and endoscopy. High-risk features such as age over 60, presence of alarm symptoms, and NSAID use should prompt urgent endoscopy.
Treatment involves eradicating H. pylori, if present, with a regimen of proton pump inhibitors and antibiotics. For NSAID-induced ulcers, discontinuation of NSAIDs and long-term PPI therapy is recommended. In refractory cases, surgery may be necessary.
Prevention strategies include judicious use of NSAIDs, H. pylori screening and eradication, and patient education. Regular follow-up is crucial to assess treatment response, monitor for complications, and ensure adherence to therapy.
In conclusion, effective management of PUD requires a comprehensive approach that encompasses a thorough understanding of the pathophysiology, accurate diagnosis and risk stratification, appropriate treatment strategies, and vigilant prevention and follow-up. By adopting such an approach, healthcare professionals can significantly improve the outcomes and quality of life of patients with PUD.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation